BMS-626529 is a member of the new drug class of HIV-1 attachment inhibitors currently in development. BMS
TemsavirTargetMol美国生化试剂,可用于动物细胞实验Product IntroductionBioactivity英文名: Temsavir描述: Temsavir (BMS626529) 是一种新型附着抑制剂,靶向
-663068 is a prodrug for BMS-626529 which binds to the viral envelope glycoprotein gp120 and interferes with attachment of the virus
to migraine painful crisis. New CGRP-R antagonist, such as BMS-927711, is in the pipeline and its developments will outline
Description:IC50 Value: 2.11 ± 0.16 nM (Ki value)[1]BMS-564929 is a novel, highly potent, orally active
BMS-509744 is a selective Itk inhibitor. BMS-509744 is useful for treatment of inflammatory and autoimmune
(BMS-663068 Tris) 是一种 HIV-1附着抑制剂。体内活性: BMS-663068 is the phosphonooxymethyl prodrug of BMS-626529, a novel small-molecule
BMS-690514 is a potent and selective inhibitor of epidermal growth factor receptor (EGFR), HER2, and HER4
BMS 433796MedChemExpress (MCE)美国BMS 433796 是一种 γ-分泌酶抑制剂,用于阿尔茨海默氏病转基因小鼠模型,可降低 Aβ 活性。BMS 433796 产品活性:BMS 433796 是一种 γ-分泌
BMS 299897MedChemExpress (MCE)美国BMS 299897 是一种磺胺类γ-secretase 抑制剂,作用于稳定过表达淀粉样前体蛋白 (APP) 的HEK293 细胞,抑制Aβ产生,IC50 为 7 nM
沃特世在ASMS 2024:超高性能新品抢眼 丰富工具解析万象
重磅!2024年影响因子正式发布 最大变化是…
李德仁、薛其坤获2023年度国家最高科学技术奖!
咨询热线: 010-84839035
联系邮箱: sales@antpedia.net